1. Home
  2. RNW vs IDYA Comparison

RNW vs IDYA Comparison

Compare RNW & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$6.34

Market Cap

2.3B

Sector

Utilities

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$29.15

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
IDYA
Founded
2011
2015
Country
United Kingdom
United States
Employees
4336
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RNW
IDYA
Price
$6.34
$29.15
Analyst Decision
Hold
Strong Buy
Analyst Count
1
16
Target Price
$7.00
$52.86
AVG Volume (30 Days)
1.4M
976.8K
Earning Date
06-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.90
EPS
N/A
N/A
Revenue
N/A
$218,710,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$11.50
$201.05
P/E Ratio
$14.63
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$4.39
$20.50
52 Week High
$8.24
$39.28

Technical Indicators

Market Signals
Indicator
RNW
IDYA
Relative Strength Index (RSI) 62.39 49.59
Support Level $5.20 $26.05
Resistance Level $7.79 $34.76
Average True Range (ATR) 0.23 1.47
MACD -0.02 0.04
Stochastic Oscillator 65.79 43.29

Price Performance

Historical Comparison
RNW
IDYA

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: